Fda Backs Abbvie's Hepatitis Treatment

U.S. regulators on Friday approved AbbVie’s new multidrug regimen for hepatitis C, and the company priced it below rival treatments from Gilead Sciences.

Topics:  abbvie s   gilead   sciences   hepatitis   treatment   
BING NEWS:
  • FDA Fully Approves AbbVie's Elahere For Ovarian Cancer
    (RTTNews) - AbbVie (ABBV) said that the U.S. Food and Drug Administration has granted full approval for Elahere (mirvetuximab soravtansine-gynx) for the treatment of folate receptor alpha-positive ...
    03/24/2024 - 2:24 am | View Link
  • AbbVie’s New ‘Biological Missile’ Ovarian Cancer Treatment Gets Full FDA Approval
    Elahere was developed by ImmunoGen, but became part of AbbVie’s portfolio after AbbVie acquired ImmunoGen for $10 billion last November. AbbVie’s purchase of ImmunoGen and Elahere specifically ...
    03/22/2024 - 10:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News